home / stock / ctso / ctso articles

CTSO Articles, CytoSorbents Corporation - From 01/09/24

Stock Information
Company Name: CytoSorbents Corporation
Stock Symbol: CTSO
Market: NASDAQ
Website: cytosorbents.com
Menu
CTSO CTSO Quote CTSO Short CTSO News CTSO Articles CTSO Message Board
Get CTSO Alerts

News, Short Squeeze, Breakout and More Instantly...
CYTOSORBENTS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cytosorbents Corporation on Behalf of Cytosorbents Stockholders and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigati...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO | Benzinga

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cytosorbents Corporation ("Cytosorbe...

Gold Moves Lower; US Crude Stocks Decline Last Week | Benzinga

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to ...

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase pro...
Crude Oil Down 1%; US Wholesale Inventories Fall In November | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up 0.14% to 37,7...

Dow Gains 50 Points; US Jobless Claims Rise To 218,000 | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Thursday. Following the market opening Thursday, the Dow...

Why Is Blood Purification Focused CytoSorbents Trading Lower Today? | Benzinga

CytoSorbents Corporation (NASDAQ: CTSO) released an update on the initial data analysis of primary safety and effectiveness endpoints and the ...
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering | Benzinga

PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditi...

CytoSorbents to Present at the 8th Annual Dawson James Conference | Benzinga

PRINCETON, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditi...

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry | Benzinga

PRINCETON, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening condit...
Previous 10 Next 10